Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of NUVL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nuvalent, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G | 5.00%3.34M shares | +0.50 ppfrom 4.50% | Apr 28, 20252 filings | Jul 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on Nuvalent, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 17, 20263:27 PM ET | Flynn James Eand 7 others | 13G/A | 0.00%0 shares | −24.21 ppfrom 24.21%Below 5% | Jul 15, 2026 | SEC |
| Jul 8, 202610:11 AM ET | FMR LLCand 1 other | 13G/A | 1.90%1.42M shares | −10.70 ppfrom 12.60%Below 5% | Jun 30, 2026 | SEC |
| May 6, 202611:30 AM ET | FMR LLCand 1 other | 13G/A | 12.60%9.25M shares | – | Mar 31, 2026 | SEC |
| Mar 27, 202611:06 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −6.85 ppfrom 6.85%Below 5% | Mar 13, 2026 | SEC |
| Feb 12, 20262:16 PM ET | Flynn James Eand 7 others | 13G/A | 24.21%22.9M shares | −3.38 ppfrom 27.59% | Dec 31, 2025 | SEC |
| Jul 17, 20258:12 PM ET | BlackRock, Inc. | 13G | 5.00%3.34M shares | +0.50 ppfrom 4.50% | Jun 30, 2025 | SEC |
| Apr 28, 20258:17 PM ET | BlackRock, Inc. | 13G/A | 4.50%2.95M shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 13, 20258:55 AM ET | Flynn James Eand 7 others | 13G/A | 27.59%23.6M shares | – | Dec 31, 2024 | SEC |
| Jan 31, 20259:54 AM ET | Vanguard Group Inc | 13G/A | 6.85%4.50M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 2023 | Fairmount Funds Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Nov 9, 2022 | Fairmount Funds Management LLC | 13GOld format | – | New | – | SEC |
| Nov 3, 2022 | Bain Capital Life Sciences Fund II, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Aug 10, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Aug 4, 2021 | Bain Capital Life Sciences Fund II, L.P. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nuvalent, Inc. shares.
No Form 144 notices for Nuvalent, Inc. are on file.